Skip to content

A clinical study of ten thousand cases of fecal microbiota transplantation in the treatment of children ASD

A clinical study of ten thousand cases of fecal microbiota transplantation in the treatment of children ASD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113281
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-05-13
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum disorder

Interventions

Pre-FMT treatment group:None
post-FMT treatment group:FMT Capsules

Sponsors

Suzhou Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 3-13 years, any gender; 2. Meet the diagnostic criteria for ASD in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) by the American Psychiatric Association; 3. Accompanied by diarrhea, constipation, bloating, and/or food allergies/intolerances, with symptoms present for at least 6 months and episodes of the above symptoms occurring in the past 3 months; 4. The participant and/or guardian has signed the informed consent form, agreeing to cooperate with the entire clinical trial process and provide clinical data as well as peripheral blood, saliva, urine, and fecal samples; 5. Able to swallow a size 3 capsule independently.

Exclusion criteria

Exclusion criteria: 1. A clear diagnosis of other neurodevelopmental disorders, such as Rett syndrome, Fragile X syndrome, etc.; 2. A history of definite organic brain diseases such as traumatic brain injury, cerebral palsy, encephalitis, etc.; 3. A clear diagnosis of other mental disorders; 4. Presence of organic intestinal lesions such as congenital megacolon, intestinal obstruction, intussusception, etc.; 5. Presence of pathological intestinal inflammatory changes, such as inflammatory bowel disease; 6. Presence of severe systemic diseases, such as severe malnutrition, severe obesity, congenital heart disease, etc.; 7. Planning to use probiotics, antibiotics, or other drugs affecting gut microbiota within the past 3 months or in the next 6 months; 8. Have received FMT treatment within the past 12 months; 9. Unable to swallow size 3 capsules.

Design outcomes

Primary

MeasureTime frame
Improvement of ASD symptoms;Improvement of gastrointestinal symptoms;Blood routine;

Secondary

MeasureTime frame
Changes in intestinal microbiota;Metabolomic alterations;

Countries

China

Contacts

Public ContactHuanlong Qin

Suzhou Municipal Hospital

qin_huanlong@126.com+86 180 0176 3088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026